Azithromycin Pd.Sol.Inf 500mg/Vial (EU CTD Available)

Product Description

Azithromycin 500mg/Vial Powder for Solution for Infusion Reference Product: Zithromax® / PFIZER 
Description: Azithromycin as powder for solution for infusion is indicated for the treatment of community-acquired pneumonia due to susceptible microorganisms in adult patients where initial intravenous therapy is required and for the treatment of pelvic inflammatory disease (PID) due to susceptible microorganisms, in patients where initial intravenous therapy is required. 
Dossier Status EU CTD Available 
Stability Studies Zone II / Zone IVb 
Shelf life: Three (3) years 
Batch Size 22,640 vials 
Pack Size BT x 1 vial

ANFARM HELLAS S.A.

  • Country/Region:
    Greece
  • On CPHI since:
    2015
Primary activities
Contract Manufacturer
Pharmaceutical Company (generic finished products)
Regulatory Affairs
Supply Chain
Specifications
  • Selling Points
    International Approvals/Standards
  • Supplied from
    Greece

ANFARM HELLAS S.A.

  • Country/Region:
    Greece
  • On CPHI since:
    2015
Primary activities
Contract Manufacturer
Pharmaceutical Company (generic finished products)
Regulatory Affairs
Supply Chain

More Products from ANFARM HELLAS S.A. (41)

  • Ceftazidime/ Avibactam Pd.C.S.Inf (2+0.5)g/vial

    Product Ceftazidime/ Avibactam Pd.C.S.Inf (2+0.5)g/vial

    Ceftazidime Avibactam is indicated in adults and pediatric patients aged 3 months and older for the treatment of the following infections:

    ·        Complicated intra-abdominal infection (cIAI)

    ·        Co...
  • Ferric Carboxymaltose Dis.Inj.If. 50mg/vial

    Product Ferric Carboxymaltose Dis.Inj.If. 50mg/vial

    Ferric Carboxymaltose Dis.Inj.If. 50mg/vial" refers to a 50 mg/mL solution of ferric carboxymaltose for injection or infusion, used to treat iron deficiency anemia and iron deficiency in heart failure
  • Fosfomycin Pd.Sol.Inf 40mg/m

    Product Fosfomycin Pd.Sol.Inf 40mg/m

    FOSFOMYCIN is indicated in all age groups for the treatment of the following infections when it is considered inappropriate to use antibacterial agents that are commonly recommended for their initial treatment:

    ·         complicated urinary tract ...
  • Vortioxetine 20 mg/ml oral drops, solution

    Product Vortioxetine 20 mg/ml oral drops, solution

    Vortioxetine increases serotonin concentrations in the brain by inhibiting its reuptake in the synapse and modulates (activates or blocks) certain serotonin receptors. This puts it in the class of serotonin modulators and stimulators.

    Vortioxetine is used as a treatment for major de...
  • Amikacin Inj.Sol 500mg/2ml (EU CTD Available) & 1g/4ml (EU CTD Available: Q3 2021)

    Product Amikacin Inj.Sol 500mg/2ml (EU CTD Available) & 1g/4ml (EU CTD Available: Q3 2021)

    Amikacin Solution for Injection 
    Reference Product: Briklin® / BRISTOL-MYERS SQUIBB
    Description: Amikacin sulfate is indicated in the short-term treatment of serious infections due to susceptible strains of Gram-negative bacteria, including Pseudomonas species,&nb...
  • Apixaban F.C. Tabs 2.5mg/tab & 5mg/tab  (under development)

    Product Apixaban F.C. Tabs 2.5mg/tab & 5mg/tab (under development)

    Apixaban Film Coated Tablets 2.5mg & 5mg
    Reference Product: Eliquis® / Bristol-Myers Squibb/Pfizer
    Description: Prevention of stroke and systemic embolism in adult patients with non-valvular atrial fibrillation (NVAF), with one or more risk factors, such as prior stroke or transie...
  • Brivaracetam Oral Solution 10mg/ml (EU CTD Available: Q4 2022)

    Product Brivaracetam Oral Solution 10mg/ml (EU CTD Available: Q4 2022)

    Brivaracetam 10mg/ml Oral Solution
    Reference Product: Briviact® / UCB
    Description: Brivaracetam is an antiepileptic agent which is indicated as adjunctive therapy in the treatment of partial onsetseizures with or without secondary generalization in adults, adolescents and children from 4 year...
  • Brivaracetam Sol. Inf 10mg/ml (5ml Vial) (EU CTD Available: Q3 2022)

    Product Brivaracetam Sol. Inf 10mg/ml (5ml Vial) (EU CTD Available: Q3 2022)

    Brivaracetam 10mg/ml (5ml Vial) Solution for Injection/Infusion
    Reference Product: Briviact® / UCB
    Description: Brivaracetam is an antiepileptic agent which is indicated as adjunctive therapy in the treatment of partial onsetseizures with or without secondary generalization in adults, adolescents and...
  • Butamirate Syr 7.5mg/5ml (200ml Bottle) (EU CTD Available)

    Product Butamirate Syr 7.5mg/5ml (200ml Bottle) (EU CTD Available)

    Butamirate Syrup 7.5mg/5ml (200ml Bottle)  
    Reference Product: Sinecod ®/ NovartisDescription: Butamiratе Syrup is used for the symptomatic treatment of non-productive (dry) cough.
    Dossier Status: EU CTD Available
    Stability Studies: Zone II / Zone I...
  • Caspofungin Pd.C.So.In 50mg/Vial & 70mg/Vial (EU CTD Available)

    Product Caspofungin Pd.C.So.In 50mg/Vial & 70mg/Vial (EU CTD Available)

    Caspofungin 50 & 70 mg/Vial Powder for Concentrate for Solution for Infusion
    Reference Product: Cancidas® / MSD
    Description: Antifungal, used for the treatment of invasive candidiasis in adult or pediatric patients, invasive aspergillosis in adultor pediatric patients who are refractory to or int...
  • Ceftaroline Fosamil Pd.C.So.In 600mg/Vial (under development)

    Product Ceftaroline Fosamil Pd.C.So.In 600mg/Vial (under development)

    Ceftaroline Fosamil Powder for Concentrate for Solution for Infusion 600mg/vial
    Reference Product: Zinforo® / Pfizer
    Description: For the treatment of the following infections in neonates, infants, children, adolescents and adults, Complicated skin and soft tissue infections (cSSTI),&...
  • Ceftriaxone Ps.Inj.Sol 1g/Vial (IM, IV) (EU CTD Available)

    Product Ceftriaxone Ps.Inj.Sol 1g/Vial (IM, IV) (EU CTD Available)

    Ceftriaxone 1g/Vial Powder for Solution for Injection/Infusion 
    Reference Product: Farcef®  / Angelini
    Description: Ceftriaxone is a cephalosporin antibacterial indicated for the treatment of the following infections caused by susceptible isolates of the desig...

ANFARM HELLAS S.A. resources (22)